AI Medical Compendium Journal:
Respiratory medicine

Showing 11 to 11 of 11 articles

A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD.

Respiratory medicine Dec 2, 2016
BACKGROUND: The contribution of fluticasone furoate (FF) on lung function in the FF/vilanterol (VI) 100/25 μg combination has been demonstrated numerically, but not statistically.
Humans Female Aged Adult Pulmonary Disease, Chronic Obstructive Male Middle Aged Glucocorticoids Quality of Life Drug Combinations Double-Blind Method Forced Expiratory Volume Drug Administration Schedule Kaplan-Meier Estimate Administration, Inhalation Androstadienes Adrenergic beta-2 Receptor Agonists Benzyl Alcohols Chlorobenzenes
View on PubMed DOI
Popular Topics
Popular Journals